Skip to main content
Novartis
language-selector-globe Austria | de
Standort wählen
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Austria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Über Uns 
      • Was wir tun 
        • Unsere Werte 
      • Geschichte 
        • Mehr als 75 Jahre Novartis in Österreich 
      • Forschung & Entwicklung 
      • Management 
      • Standorte in Österreich 
      • Unsere Strategie 
      • Diversity and Inclusion 
      • Arbeiten bei Novartis Österreich 
      • Produkte 
      Über uns Über Uns
    • Betroffene & Angehörige 
      • Unser Versprechen an Patientinnen und Patienten 
      • Patient Engagement 
        • Diabetisches Makulaödem (DMÖ) 
        • Brustkrebs 
        • Altersbedingte Makuladegeneration (AMD) 
        • Erblich bedingte Netzhautdystrophien (IRD) 
        • Webseiten & Apps 
      • Erkrankungen & Therapien 
        • Atemwegserkrankungen 
        • Augenerkrankungen 
        • Dermatologie 
        • Hämatologie 
        • Herz-Kreislauf-Erkrankungen 
        • Onkologie 
        • Rheumatologie 
        • Transplantation 
      • Produkte 
        • Innovative Medikamente 
        • Generika & Biosimilars 
        • Gen & Zelltherapien 
        • Produkte von A-Z 
      • Nebenwirkungen melden 
      • Klinische Studien 
        • Allgemeines 
        • Wissenswertes zu klinischen Studien 
        • Aktuelle Studien 
          • Chronische Myeloische Leukämie in der chronischer Phase (CML-CP): CABL001A2302 
        • Fachausdrücke 
        • Häufig gestellte Fragen zur Studienteilnahme 
        • Onkologische Studien 
      • Fragen & Nebenwirkungen 
        • Meine Fragen - medizinischen Informationsdienst von Novartis 
        • Meine Fragen - Arzt 
        • Meine Fragen - Apotheker 
      • Patientenportal 
      Teaser Patient*innen & Angehörige 280px Betroffene & Angehörige
    • Fachkreise 
      • Serviceportal 
      • Produkte 
      • Novartis Pipeline 
      • Nebenwirkungen melden 
      • Aktuelle Klinische Studien 
      • Novartis Clinical Trials 
      • Terminanfrage 
      Teaser Fachkreise 280px Fachkreise
    • Nachhaltigkeit 
      • Unternehmensethik 
        • Offenlegungen 
      • Zugang zu Medikamenten 
      • Umwelt & Gesellschaft 
      • Ethik, Risiko und Compliance 
        • SpeakUp 
      Nachhaltigkeit Nachhaltigkeit
    • Medien 
      • Pressemitteilungen 
      • Geschichten 
      • Unternehmenspublikationen 
      • Bildmaterial 
      • Medienkontakt 
    • Kontakt 
    • Karriere 
      • Jobsuche 
      • Arbeiten bei Novartis Österreich 
        • Sommer-/Ferialpraktikum 2024 
      • Mitarbeitende 
      • Karriere-Programme 
      • Lehre 
      • Meet the teams 
      Teaser Karriere 525x280px Karriere
    Banner Novartis Medien Startseite
  1. Home
  2. Karriere
  3. Jobsuche
  • Sort by Sort ascending
  • Positionsbezeichnung
  • Site
  • Standort
  • Division
  • Business
  • Functional Area Sort descending
  • Erscheinungsdatum
Positionsbezeichnung Site Standort Division Business Functional Area Sort descending Erscheinungsdatum
Business Data Migration Expert – Procurement Hyderabad (Office) Indien Operations CTS BD&L & Strategic Planning Okt 02, 2024
Exec. Director, Therapeutic Area Strategy, Cardiovascular Cambridge (USA) USA Strategy & Growth Innovative Medicines BD&L & Strategic Planning Okt 08, 2024
Lead Consultant Prague Tschechische Republik Operations CTS BD&L & Strategic Planning Okt 10, 2024
Senior Consultant Prague Tschechische Republik Operations CTS BD&L & Strategic Planning Okt 10, 2024
Business Data Migration Expert - Manufacturing Hyderabad (Office) Indien Operations CTS BD&L & Strategic Planning Mai 14, 2024
Site Operations Lead Selangor Malaysia Operations CTS BD&L & Strategic Planning Okt 08, 2024
Senior Consultant – M&A Post-merger Integrations | Separations Prague Tschechische Republik Operations CTS BD&L & Strategic Planning Okt 09, 2024
Lead Consultant – M&A Post-merger Integrations | Separations Prague Tschechische Republik Operations CTS BD&L & Strategic Planning Okt 09, 2024
In-Market Brands Lead Jordan Jordanien International Innovative Medicines BD&L & Strategic Planning Okt 16, 2024
Senior Manager - Compliance and Risk Operations Hyderabad (Office) Indien Operations CTS Legal & Intellectual Property & Compliance Sep 18, 2024
Functional Lead, Compliance Analytics and Reporting Telangana Indien Operations CTS Legal & Intellectual Property & Compliance Sep 18, 2024
Associate Director, Data Privacy, Digital & AI East Hanover USA Ethics Risk & Compliance Corporate Legal & Intellectual Property & Compliance Sep 04, 2024
Sr Manager/Manager-Monitoring Shanghai (Shanghai) China Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compliance Jul 18, 2024
Patent Paralegal Cambridge (USA) USA Legal Pharma Research Legal & Intellectual Property & Compliance Jul 19, 2024
Senior Legal Counsel Shanghai (Shanghai) China Legal Innovative Medicines Legal & Intellectual Property & Compliance Jul 02, 2024
Associate Director ERC Risk&Operations, Corporate Functions Selangor Malaysia Ethics Risk & Compliance Corporate Legal & Intellectual Property & Compliance Aug 29, 2024
Senior IP Specialist / Patent Attorney Basel (City) Schweiz Legal Innovative Medicines Legal & Intellectual Property & Compliance Sep 30, 2024
Manager- Data Privacy Review and Remediation Telangana Indien Ethics Risk & Compliance Corporate Legal & Intellectual Property & Compliance Okt 10, 2024
Associate Director - Risk & Assurance, EUROPE Prague Tschechische Republik Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compliance Okt 11, 2024
Head DPDAI China Shanghai (Shanghai) China Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compliance Okt 14, 2024
Manager- Data Privacy Review and Remediation Selangor Malaysia Ethics Risk & Compliance Corporate Legal & Intellectual Property & Compliance Okt 14, 2024
Head of R&D Legal, R&D Transactions and Technical Research & Development Cambridge (USA) USA Legal Pharma Research Legal & Intellectual Property & Compliance Okt 15, 2024
Risk & Assurance Manager Mumbai (Head Office) Indien Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compliance Okt 16, 2024
Country ERC Head, India Mumbai (Office) Indien Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compliance Okt 16, 2024
Ethics, Risk & Compliance Manager Selangor Malaysia Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compliance Aug 22, 2024
Head of R&D Legal, R&D Transactions and Technical Research & Development Basel (City) Schweiz Legal Innovative Medicines Legal & Intellectual Property & Compliance Okt 16, 2024
Vice President, Head of R&D Legal, Americas Cambridge (USA) USA Legal Corporate Legal & Intellectual Property & Compliance Okt 17, 2024
Executive Director, R&D Legal and FDA Regulatory Legal Lead East Hanover USA Legal Corporate Legal & Intellectual Property & Compliance Okt 17, 2024
Cardiovascular Territory Account Specialist – Falls Church – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 17, 2024
Cardiovascular Institutional Sales Specialist– Boston – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 17, 2024
Executive Product Specialist Quanzhou (Fujian Province) China International Innovative Medicines Der Umsatz Sep 18, 2024
KAM/Senior KAM - Oncology - North London Field Force (England / Wales) Vereinigtes Königreich International Innovative Medicines Der Umsatz Sep 20, 2024
Allergy Territory Account Specialist - Los Angeles, CA (East) - Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 23, 2024
Allergy Territory Account Specialist - Chicago, IL (North) - Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 23, 2024
MR Wuhan (Hubei Province) China International Innovative Medicines Der Umsatz Jul 28, 2024
County Executive Xiaogan (Hubei Province) China International Innovative Medicines Der Umsatz Jul 28, 2024
Senior Sales Representative - Ophthalmology Mapletree Business City (MBC) Singapur International Innovative Medicines Der Umsatz Jul 30, 2024
Senior MR Guangzhou (Guangdong Province) China International Innovative Medicines Der Umsatz Jul 30, 2024
MR Fuyang (Anhui Province) China International Innovative Medicines Der Umsatz Aug 05, 2024
Senior/Advanced Medical/Sales Representative Beijing (Beijing) China International Innovative Medicines Der Umsatz Aug 06, 2024
Customer Engagement &Solution Partner Lithuania Litauen International Innovative Medicines Der Umsatz Aug 29, 2024
(高级)医药代表 /(资深)产品专员 Xianyang (Shanxi Province) China International Innovative Medicines Der Umsatz Aug 30, 2024
MR Beijing (Beijing) China International Innovative Medicines Der Umsatz Sep 01, 2024
Medical Representative - CVRM Mapletree Business City (MBC) Singapur International Innovative Medicines Der Umsatz Sep 02, 2024
Key Account Manager , Haematology - Yorkshire, East Midlands, Northamptonshire. Field Force (England / Wales) Vereinigtes Königreich International Innovative Medicines Der Umsatz Sep 03, 2024
Allergy- Territory Account Specialist – Akron, OH– Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 10, 2024
Allergy-Territory Account Specialist – Flint, MI – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 10, 2024
Allergy-Territory Account Specialist – Ann Arbor, MI – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 10, 2024
Allergy Territory Account Specialist - Chicago, IL (South) - Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 11, 2024
Portfolio Account Specialist (Immunology, Part Time) Western Australia (WA) Australien International Innovative Medicines Der Umsatz Sep 11, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 42
  • › Next page

Novartis Österreich

Novartis entdecken
  • Über Uns
  • Betroffene & Angehörige
  • Fachkreise
  • Medien
  • Karriere
Medienbereich
  • Pressemitteilungen
  • Geschichten
Unser Portfolio
  • Arzneimittel der Novartis
Weitere Novartis Websites
  • Healthcare Professional Resources
  • Global site
Footer Bottom
© 2024 Novartis Pharma GmbH
  • Datenschutzerklärung
  • Nutzungsbedingungen
  • Über Cookies
  • Impressum
  • Cookie-Einstellungen
  • Barrierefreiheit im Internet
  • Site Map
Novartis Site Directory
Diese Website richtet sich an Personen in Österreich.